Evidence map›Paper›PMID 42076554›Full record

ArticleSensors (Basel, Switzerland)2026

A Dual-Source Evidence-Driven Semi-Supervised Belief Rule Base for Fault Diagnosis.

Xin Zhang, Zhiying Fan, Wei He, Huafeng He

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xin ZhangHigh-Tech Institute of Xi'an, Xi'an 710025, China.
Zhiying FanSchool of Computer Science and Information Engineering, Harbin Normal University, Harbin 150025, China.ORCID 0009-0005-8185-8301
Wei HeSchool of Computer Science and Information Engineering, Harbin Normal University, Harbin 150025, China.ORCID 0000-0003-4523-8242
Huafeng HeHigh-Tech Institute of Xi'an, Xi'an 710025, China.

Funding

Natural Science Foundation of Heilongjiang Province PL2025F015
6 · The paper itself

Abstract

In the fault diagnosis of complex industrial systems, labeled samples are expensive to obtain, which leads to insufficient training data for the belief rule base (BRB) model. Although unlabeled samples are abundant, the uncertainty of their pseudo-labels may undermine semi-supervised learning and hinder accurate parameter optimization of the BRB model. To address these issues, a dual-source evidence-driven semi-supervised BRB method (SS-BRB) is proposed for fault diagnosis. The proposed method makes effective use of unlabeled samples while preserving the interpretability and inference transparency of the BRB model. To improve the reliability of pseudo-labels in semi-supervised learning, a dual-source evidence-driven pseudo-labeling mechanism is designed. In this mechanism, local similarity information is combined with the global inference results of the BRB model. An entropy factor and a feature distance factor are introduced to adaptively adjust the confidence of pseudo-labels. In this way, the quality of pseudo-labels is improved, and the influence of noisy samples is reduced. Based on this mechanism, high-confidence pseudo-labeled samples are incorporated into the training set to further optimize the model. Experimental results show that the proposed method achieves good diagnostic performance on both the gearbox dataset and the WD615 diesel engine dataset. Even with limited labeled data, the proposed method still achieves high accuracy, robustness, and good generalization performance.

Indexed as

belief rule base (BRB)fault diagnosispseudo-labelingsemi-supervised learning

Identifiers

PMID42076554
PMCPMC13120282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.